Neuropharmacology and analgesiaProtective effects of Tetramethylpyrazine (cas 1124-11-4) analogue Z-11 on cerebral ischemia reperfusion injury
-
Add time:09/28/2019 Source:sciencedirect.com
The aim of our study was to investigate the effects of a new synthetic compound (E) -1- (E) -1- (2- hydroxy -5- chlorophenyl) -3- (3, 5, 6- three methyl pyrazine -2- based) -2- propylene -1 ketone, Z-11, a Tetramethylpyrazine (cas 1124-11-4) analogue, on cerebral ischemia reperfusion injury and the underlying mechanism. 240–260 g adult male Wistar rats were subjected to middle cerebral artery occlusion for 2 h, followed by 22 h of reperfusion. Z-11 (1.7, 3.4 and 6.8 mg/kg, i.p.), Edaravone (3 mg/kg, i.p.) and DMSO (1‰, i.p.) was administered at 2 h after the onset of ischemia. The rats’ neurological score, infarct volume, and body weight change were tested, and some oxidative stress markers such as superoxide dismutase (SOD) activity, glutathione (GSH) and malondialdehyde (MDA) contents were evaluated after 22 h of reperfusion. Results showed that neurologic deficit, infarct volume and body weight change were ameliorated after cerebral ischemia reperfusion, and that Z-11 exhibits an excellent effect at a dosage of 6.8 mg/kg. This dose also reduced the content of MDA, and upregulated SOD activity and GSH content. Similarly, 6.8 mg/kg Z-11 treatment inhibited the reactive oxygen species content and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, with the protein levels of Ras-related C3 botulinum toxin substrate1(Rac-1) and mitogenic oxidase (Nox2) downregulated even further. Moreover, the protein levels of nuclear factor erythroid 2-related factor 2 (Nrf2) and its downstream anti-oxidant protein heme oxygenase-1 (HO-1) were upregulated. This indicates that Z-11 could play a protective role in cerebral ischemia–reperfusion injury, and that the protective effect of Z-11 may be related to improvements in the antioxidant capacity of brain tissue. The mechanisms are associated with enhancing oxidant defence systems via the activation of Nrf2/HO-1 and Rac-1/NADPH oxidase pathways.
We also recommend Trading Suppliers and Manufacturers of Tetramethylpyrazine (cas 1124-11-4). Pls Click Website Link as below: cas 1124-11-4 suppliers
Prev:Effects of Tetramethylpyrazine (cas 1124-11-4) from Chinese black vinegar on antioxidant and hypolipidemia activities in HepG2 cells
Next:Tetramethylpyrazine (cas 1124-11-4) ameliorates experimental autoimmune encephalomyelitis by modulating the inflammatory response) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Full length articleTetramethylpyrazine (cas 1124-11-4) attenuates blood-brain barrier disruption in ischemia/reperfusion injury through the JAK/STAT signaling pathway09/30/2019
- Tetramethylpyrazine (cas 1124-11-4) ameliorates experimental autoimmune encephalomyelitis by modulating the inflammatory response09/29/2019
- Effects of Tetramethylpyrazine (cas 1124-11-4) from Chinese black vinegar on antioxidant and hypolipidemia activities in HepG2 cells10/01/2019
- GC–FID determination of Tetramethylpyrazine (cas 1124-11-4) and acetoin in vinegars and quantifying the dependence of Tetramethylpyrazine (cas 1124-11-4) on acetoin and ammonium09/27/2019
- Thermodynamics, molecular modelling and denaturation studies on exploring the binding mechanism of Tetramethylpyrazine (cas 1124-11-4) with human serum albumin09/26/2019
- Analytical MethodsDispersive liquid–liquid microextraction for rapid and inexpensive determination of Tetramethylpyrazine (cas 1124-11-4) in vinegar09/25/2019
- High yield of Tetramethylpyrazine (cas 1124-11-4) in functional Fuqu using bacillus amyloliquefaciens09/24/2019